Stock listing

XE9 Stock Price, News, Filings & Events — Xencor, Inc.

Selected listing: XE9 · SWB · EUR · DE

XE9:SWB represents Xencor, Inc., a biopharmaceutical company focused on developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases. The company is actively engaged in clinical trials and has made recent announcements regarding its pipeline advancements and collaborations. Investors can find relevant filings and updates on upcoming events that may impact the company's market position. Xencor's innovative approach in the biopharmaceutical sector continues to attract attention in the evolving healthcare landscape.